热门资讯> 正文
Fennec Pharmaceuticals GAAP EPS—0.10美元错过0.08美元
2024-03-21 23:29
- Fennec Pharmaceuticals press release (NASDAQ:FENC): Q4 GAAP EPS of -$0.10 misses by $0.08.
- Pro forma fourth quarter cash in excess of $55 million
More on Fennec Pharmaceuticals
- Fennec Pharmaceuticals: Great Sales Progress - Not Yet Reflected In Stock Price
- Seeking Alpha’s Quant Rating on Fennec Pharmaceuticals
- Historical earnings data for Fennec Pharmaceuticals
- Financial information for Fennec Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
